BTSA1 protects mice from BLM‐induced pulmonary fibrosis by selectively eliminating senescent myofibroblasts via direct activation of BAX, and can be used as a novel senolytic drug for IPF for reversing established fibrosis. Here, BAX is linked to pulmonary fibrosis.